GlassScriptPhysician profile
Larry Froch
NPI 1104944727
$1,616.58
in general payments reported to CMS, 2019-2025
18 companies · $11.77 in 2025
The $11.77 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $103 · 2021: $175 · 2023: $339 · 2024: $293 · 2025: $11.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632 · Education: $11.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.33 |
| Education | $11.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $313.76 | 2019-2024 | Jynarque |
| Vifor Pharma, INC. | $174.53 | 2019-2024 | Veltassa |
| Astrazeneca Pharmaceuticals LP | $163.59 | 2019-2024 | Lokelma, Farxiga |
| Bard Peripheral Vascular, INC. | $143.81 | 2019 | |
| Glaxosmithkline, LLC. | $129.78 | 2023-2024 | Jesduvroq, Benlysta |
| Amgen INC. | $109.82 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.09 | 2023-2024 | Jardiance |
| Daiichi Sankyo INC. | $85.12 | 2019 | |
| Opko Pharmaceuticals, LLC | $85.08 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $75.81 | 2019 | |
| Horizon Therapeutics Plc | $72.00 | 2019-2021 | |
| Travere Therapeutics, INC. | $31.84 | 2023-2025 | Filspari |
| Ardelyx, INC. | $30.85 | 2024 | Ibsrela |
| Mallinckrodt Hospital Products INC. | $25.46 | 2024 | Terlivaz |
| Fresenius USA Marketing, INC. | $24.36 | 2024 | Velphoro |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $22.47 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.00 | 2021 | |
| Novo Nordisk INC | $17.21 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Froch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.